Oxysterols and neurodegenerative diseases

被引:235
作者
Bjorkhem, Ingemar [1 ]
Cedazo-Minguez, Angel [2 ]
Leoni, Valerio [3 ]
Meaney, Steve [4 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Huddinge 14186, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Neurotec Dept, Huddinge 14186, Sweden
[3] C Besta Neurol Inst, Div Biochem & Genet, Milan, Italy
[4] Dublin Inst Technol, Fac Sci, Sch Biol Sci, Dublin, Ireland
关键词
Blood-brain barrier; 24S-Hydroxycholesterol; 27-Hydroxycholesterol; beta-Amyloid; Activity regulated cytoskeleton-associated protein; CYP27; CYP46; CHOLESTEROL-BIOSYNTHESIS PATHWAY; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL REGULATION; MULTIPLE-SCLEROSIS; PLASMA-LEVELS; 24S-HYDROXYCHOLESTEROL CEREBROSTEROL; CYTOCHROME-P450; 46A1; HUNTINGTONS-DISEASE;
D O I
10.1016/j.mam.2009.02.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood-brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (245-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain. The opposite flux of 27-hydroxycholesterol (27-OHC) from the circulation into the brain may regulate a number of key enzymes within the brain. In vitro experiments suggest that the balance between the levels of these two molecules may be of importance for the generation of beta-amyloid peptides. In primary cultures of rat hippocampal cells 27-OHC is able to suppress expression of the activity regulated cytoskeleton-associated protein (Arc), a protein important in memory consolidation which is reduced in patients with Alzheimer's disease (AD). In the present work we explore the possibility that the flux of 27-OHC from the circulation into the brain represents the missing link between AD and hypercholesterolemia, and discuss the possibility that modification of this flux may be a therapeutic strategy. Lastly, we discuss the use of oxysterols as diagnostic markets in neurodegenerative disease. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 50 条
  • [41] Microglia-targeting nanotherapeutics for neurodegenerative diseases
    Zhao, Nanxia
    Francis, Nicola L.
    Calvelli, Hannah R.
    Moghe, Prabhas, V
    APL BIOENGINEERING, 2020, 4 (03)
  • [42] Nanotechnology: Its Application in Treating Neurodegenerative Diseases
    Naz, Falaq
    Siddique, Yasir Hasan
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (01) : 34 - 53
  • [43] Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?
    Muddapu, Vignayanandam Ravindernath
    Dharshini, S. Akila Parvathy
    Chakravarthy, V. Srinivasa
    Gromiha, M. Michael
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [44] Microbial Immuno-Communication in Neurodegenerative Diseases
    Main, Bevan S.
    Minter, Myles R.
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [45] Viruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases
    Roemer, Christine
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [46] Mendelian randomization identifies proteins involved in neurodegenerative diseases
    Belbasis, Lazaros
    Morris, Sam
    van Duijn, Cornelia
    Bennett, Derrick
    Walters, Robin
    BRAIN, 2025,
  • [47] Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases
    Utpal, Biswajit Kumar
    Al Amin, Md
    Zehravi, Mehrukh
    Sweilam, Sherouk Hussein
    Arjun, Uppuluri Varuna Naga Venkata
    Madhuri, Y. Bala
    Gupta, Jeetendra Kumar
    Yaidikar, Lavanya
    Tummala, Tanuja
    Suseela, R.
    Durairaj, Akiladevi
    Reddy, Konatham Teja Kumar
    Al Fahaid, Ali Audah Fahaid
    Rab, Safia Obaidur
    Almahjari, Mohammed Saeed
    Emran, Talha Bin
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025,
  • [48] Estrogen-BDNF interactions: Implications for neurodegenerative diseases
    Sohrabji, Farida
    Lewis, Danielle K.
    FRONTIERS IN NEUROENDOCRINOLOGY, 2006, 27 (04) : 404 - 414
  • [49] Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases
    Volkman, Rotem
    Offen, Daniel
    STEM CELLS, 2017, 35 (08) : 1867 - 1880
  • [50] Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
    Meredith, M. Elizabeth
    Salameh, Therese S.
    Banks, William A.
    AAPS JOURNAL, 2015, 17 (04): : 780 - 787